Is Pro-Natriuretic Peptide Increased in Kidney Failure?
Yes, both BNP and NT-proBNP are markedly increased in acute or chronic renal failure due to impaired renal clearance, and both peptides are cleared renally to a similar extent. 1
Mechanism of Elevation in Kidney Failure
Renal Clearance Pathways
NT-proBNP is predominantly cleared by the kidneys, accounting for 55–65% of total body clearance, with the liver clearing 20–25%, musculoskeletal tissue 10–15%, and head/neck 5–10%. 1
BNP is cleared via clearance receptors (NP receptor-C) and neutral endopeptidase, but renal extraction still accounts for 15–20% in healthy individuals—identical to NT-proBNP. 1
Both BNP and NT-proBNP extraction fractions are equally dependent on renal function, even in the presence of hypertension. 1
Degree of Elevation by Severity of Kidney Disease
NT-proBNP renal extraction is maintained in moderate kidney dysfunction (eGFR ≥30 mL/min/1.73 m²). 1
In severe renal dysfunction (eGFR <30 mL/min/1.73 m²), the NT-proBNP/BNP ratio increases disproportionately for unclear reasons. 1
NT-proBNP shows an exponential increase with declining eGFR, particularly in CKD stages 4–5, where a 15-unit decrease in eGFR is associated with a 1.80-fold to 3.50-fold increase in log(NT-proBNP). 2
The correlation between eGFR and NT-proBNP is strong (r = −0.525, P <0.001), far exceeding the correlation with other biomarkers. 3
Clinical Implications for Interpretation
Adjusted Diagnostic Cutoffs in Kidney Failure
For acute heart failure diagnosis in patients with eGFR <60 mL/min/1.73 m², double the upper reference limit for BNP to 200 pg/mL. 1
For NT-proBNP in renal dysfunction, use a higher threshold of 1,200 pg/mL or age-adjusted cutoff values. 1
In heart failure with preserved ejection fraction (HFpEF) and CKD, the NT-proBNP cutoff should be raised to 750 pg/mL when eGFR is <60 mL/min/1.73 m², compared to 250 pg/mL in patients without CKD. 4
For diagnosis of acute decompensated heart failure in patients with renal dysfunction, the median optimal cutpoint is 1,980 pg/mL (AUC 0.66–0.89), compared to 450 pg/mL (AUC 0.72–0.95) in patients with preserved renal function. 5
Prognostic Value Remains Intact Despite Elevation
Elevated NT-proBNP retains strong prognostic value regardless of renal function, with each doubling in NT-proBNP associated with a 37% relative increase in heart failure hospitalization or cardiovascular death (HR 1.37,95% CI 1.34–1.41), consistent across all eGFR categories. 6
The same NT-proBNP concentration predicts substantially higher absolute risk of adverse outcomes in patients with eGFR <45 mL/min/1.73 m² compared to those with eGFR ≥60 mL/min/1.73 m²—NT-proBNP levels are approximately 2.5- to 3.5-fold lower for the same incidence of adverse events. 6
In patients with advanced CKD and anemia, NT-proBNP ≥1,000 pg/mL confers an 8-fold increased risk of cardiovascular outcomes (HR 8.10,95% CI 2.80–23.40) and a 1.77-fold increased risk of renal outcomes (HR 1.77,95% CI 1.36–2.31) compared to levels <250 pg/mL. 7
The unadjusted pooled risk ratio for NT-proBNP and mortality is similar in patients with renal dysfunction (3.25,95% CI 2.45–4.30) compared to those with preserved renal function (3.01,95% CI 2.53–3.58). 5
Critical Caveats
Do Not Dismiss Elevated Levels as "False Positives"
Elevated NT-proBNP in the absence of heart failure reflects genuine pathological ventricular stress and is independently associated with adverse outcomes and increased mortality—it should never be dismissed as a false positive. 1, 8
Acute or chronic renal failure is explicitly listed among diseases that increase natriuretic peptides, alongside heart failure, valvular disease, atrial fibrillation, pulmonary embolism, sepsis, and severe neurological disease. 1
Exclusion from Clinical Trials
- Patients with end-stage renal disease or receiving renal replacement therapy should be excluded from enrollment via natriuretic peptides in clinical trials, given contraindications to most guideline-directed medical therapies and chronically elevated baseline levels. 1
Interaction with Other Confounders
When multiple confounders coexist—advanced age, renal disease, atrial fibrillation, obesity—NT-proBNP values can exceed standard heart failure thresholds, mandating cautious interpretation but not dismissal. 1, 8
In patients with moderate-to-severe acute kidney injury, the highest quartile of NT-proBNP (≥18,215 pg/mL) is associated with increased likelihood of dialysis requirement (adjusted OR 2.36,95% CI 1.87–2.99), dialysis dependence (adjusted OR 1.89,95% CI 1.34–2.53), and in-hospital mortality (adjusted OR 1.34,95% CI 1.01–1.34). 9